Tags

Type your tag names separated by a space and hit enter

Coagulopathy and Plausible Benefits of Anticoagulation Among COVID-19 Patients.
Curr Probl Cardiol. 2020 Sep; 45(9):100648.CP

Abstract

The exceptional outbreak of COVID-19 pandemic has let the scientific community to work closely and quickly learnt things in a very short period of time. This has let us recognize that thromboembolic complications are responsible for morbidity and mortality among the COVID-19 infected patients. Available data have suggested a possible multifactorial basis of these complications, and while efforts are being made to treat this infection, preventive measures with the use of systemic anticoagulation were quickly adopted to deal with this issue. Despite obvious benefits as appeared with the use of systemic anticoagulation, most of the emerged data were retrospective, hence raise questions on the possible interplay of the confounders as well as long-term benefits and safety of systemic anticoagulation.

Authors

No affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

32703535

Citation

Ahmed, Syed Imran, and Shahzad Khan. "Coagulopathy and Plausible Benefits of Anticoagulation Among COVID-19 Patients." Current Problems in Cardiology, vol. 45, no. 9, 2020, p. 100648.
Ahmed SI, Khan S. Coagulopathy and Plausible Benefits of Anticoagulation Among COVID-19 Patients. Curr Probl Cardiol. 2020;45(9):100648.
Ahmed, S. I., & Khan, S. (2020). Coagulopathy and Plausible Benefits of Anticoagulation Among COVID-19 Patients. Current Problems in Cardiology, 45(9), 100648. https://doi.org/10.1016/j.cpcardiol.2020.100648
Ahmed SI, Khan S. Coagulopathy and Plausible Benefits of Anticoagulation Among COVID-19 Patients. Curr Probl Cardiol. 2020;45(9):100648. PubMed PMID: 32703535.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Coagulopathy and Plausible Benefits of Anticoagulation Among COVID-19 Patients. AU - Ahmed,Syed Imran, AU - Khan,Shahzad, Y1 - 2020/06/27/ PY - 2020/05/27/received PY - 2020/06/15/revised PY - 2020/06/19/accepted PY - 2020/7/25/pubmed PY - 2020/8/14/medline PY - 2020/7/25/entrez SP - 100648 EP - 100648 JF - Current problems in cardiology JO - Curr Probl Cardiol VL - 45 IS - 9 N2 - The exceptional outbreak of COVID-19 pandemic has let the scientific community to work closely and quickly learnt things in a very short period of time. This has let us recognize that thromboembolic complications are responsible for morbidity and mortality among the COVID-19 infected patients. Available data have suggested a possible multifactorial basis of these complications, and while efforts are being made to treat this infection, preventive measures with the use of systemic anticoagulation were quickly adopted to deal with this issue. Despite obvious benefits as appeared with the use of systemic anticoagulation, most of the emerged data were retrospective, hence raise questions on the possible interplay of the confounders as well as long-term benefits and safety of systemic anticoagulation. SN - 1535-6280 UR - https://www.unboundmedicine.com/medline/citation/32703535/Coagulopathy_and_Plausible_Benefits_of_Anticoagulation_Among_COVID_19_Patients_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0146-2806(20)30125-0 DB - PRIME DP - Unbound Medicine ER -